Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 123 of 123 entries
Sorted by: Best Match Show Resources per page
An optimized imaging protocol for [.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Schatka I, Bingel A, Schau F, Bluemel S, Messroghli DR, Frumkin D, Knebel F, Diekmann SM, Elsanhoury A, Tschöpe C, Hahn K, Amthauer H, Rogasch JMM, Wetz C.
PMID: 34331215
J Nucl Cardiol. 2021 Dec;28(6):2483-2496. doi: 10.1007/s12350-021-02715-6. Epub 2021 Jul 30.

BACKGROUND: In [METHODS: In SPECT/CT phantom measurements (NaI cameras, N = 2; CZT, N = 1), peak contrast recovery (CRpeak) was derived from sphere inserts or myocardial insert (cardiac phantom; signal-to-background ratio [SBR], 10:1 or 5:1). In 25 positive...

An optimized imaging protocol for [.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Schatka I, Bingel A, Schau F, Bluemel S, Messroghli DR, Frumkin D, Knebel F, Diekmann SM, Elsanhoury A, Tschöpe C, Hahn K, Amthauer H, Rogasch JMM, Wetz C.
PMID: 34331215
J Nucl Cardiol. 2021 Dec;28(6):2483-2496. doi: 10.1007/s12350-021-02715-6. Epub 2021 Jul 30.

BACKGROUND: In [METHODS: In SPECT/CT phantom measurements (NaI cameras, N = 2; CZT, N = 1), peak contrast recovery (CRpeak) was derived from sphere inserts or myocardial insert (cardiac phantom; signal-to-background ratio [SBR], 10:1 or 5:1). In 25 positive...

Interventricular Differences of Signaling Pathways-Mediated Regulation of Cardiomyocyte Function in Response to High Oxidative Stress in the Post-Ischemic Failing Rat Heart.

Antioxidants (Basel, Switzerland)

Kovács Á, Herwig M, Budde H, Delalat S, Kolijn D, Bódi B, Hassoun R, Tangos M, Zhazykbayeva S, Balogh Á, Czuriga D, Van Linthout S, Tschöpe C, Dhalla NS, Mügge A, Tóth A, Papp Z, Barta J, Hamdani N.
PMID: 34208541
Antioxidants (Basel). 2021 Jun 16;10(6). doi: 10.3390/antiox10060964.

Standard heart failure (HF) therapies have failed to improve cardiac function or survival in HF patients with right ventricular (RV) dysfunction suggesting a divergence in the molecular mechanisms of RV vs. left ventricular (LV) failure. Here we aimed to...

Showing 121 to 123 of 123 entries